The Biden administration is expected to release the next batch of drugs that will be subject to Medicare price negotiations — ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

British fund manager Terry Smith has sold his stake in Diageo Plc, citing concerns about the management of the drinks company ...

Financing was co-led by Forbion and General Atlantic, with participants such as RA Capital Management, OrbiMed, and Lilly ...

Influencer Liv Schmidt was recently banned from TikTok, but her popularity speaks to the risks 'Skinny Influencers' pose to ...

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...

Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

Country may have reached its peak for obesity levels, according to one of biggest online sellers of medications ...